Sarcoma: Evaluation of Immunotherapy Using Dendritic Cells – Cancer Therapy Advisor
|
Sarcoma: Evaluation of Immunotherapy Using Dendritic Cells
Cancer Therapy Advisor Dendritic cell–based immunotherapy does not improve outcomes for patients with refractory sarcoma, according to the results of a phase 1/2 study published in Cancer.1. Relapsed sarcomas are often unresponsive to chemotherapy, limiting treatment options … |
